Press Releases TRACON Pharmaceuticals, Inc.

Equities

TCON

US89237H3084

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-31 pm EDT			5-day change	1st Jan Change
1.28 ^USD	+2.40%		-14.09%	-63.45%

May. 14	TRACON Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
May. 14	Transcript : TRACON Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 14, 2024

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Tracon: Q1 Earnings Snapshot	May. 14	AQ
TRACON Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update	May. 14	AQ
TRACON to Report First Quarter 2024 Financial Results and Provide Corporate Update on May 14, 2024	May. 07	AQ
TRACON Pharmaceuticals Announces Reverse Stock Split	Apr. 08	AQ
TRACON Pharmaceuticals Provides Update on Ongoing ENVASARC Phase 2 Pivotal Trial Following Independent Data Monitoring Committee Recommendation to Continue the Trial as Planned	Apr. 03	AQ
Tracon: Q4 Earnings Snapshot	Mar. 05	AQ
TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update	Mar. 05	AQ
TRACON to Report Fourth Quarter and Year-End 2023 Financial Results and Provide Corporate Update on March 5, 2024	Feb. 28	AQ
TRACON Pharmaceuticals Provides Positive Update on Ongoing ENVASARC Pivotal Phase 2 Trial	Dec. 20	AQ
TRACON Pharmaceuticals Announces License of Product Development Platform for $3.0 Million Upfront Payment	Nov. 20	AQ
Tracon: Q3 Earnings Snapshot	Nov. 09	AQ
TRACON Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update	Nov. 09	AQ
TRACON to Report Third Quarter 2023 Financial Results and Provide Corporate Update on November 9, 2023	23-10-31	AQ
TRACON Pharmaceuticals Announces ENVASARC Phase 2 Pivotal Trial Exceeded Futility Threshold at Final Interim Analysis and Will Continue as Planned	23-09-18	AQ
TRACON Pharmaceuticals Announces Participation at Upcoming Investor Conferences	23-09-05	AQ
Tracon: Q2 Earnings Snapshot	23-08-14	AQ
TRACON Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update	23-08-14	AQ
TRACON to Report Second Quarter 2023 Financial Results and Provide Corporate Update on August 14, 2023	23-08-02	AQ
TRACON Pharmaceuticals Announces Collection of Arbitration Award from I-Mab Biopharma	23-07-11	AQ
TRACON Pharmaceuticals Announces Positive Results Based on Ongoing Double-Digit Objective Response Rate for Single Agent Envafolimab in the ENVASARC Phase 2 Pivotal Trial	23-06-20	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases TRACON Pharmaceuticals, Inc.

Equities

TCON

US89237H3084

Press Releases

Filters